Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Van Tintelen JP, Ware JS, Kaski JP; ESC Scientific Document Group (2023) ESC Guidelines for the management of cardiomyopathies. Eur Heart J 44(37):3503−3626. https://doi.org/10.1093/eurheartj/ehad194. PMID: 37622657
Mahfouz Badran H, Soltan G, Eltahan E, Yacoub MH, Faheem N (2021) Relation of atrial electromechanical delay to P-wave dispersion on surface ECG using vector velocity imaging in patients with hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol 26(1):e12801. https://doi.org/10.1111/anec.12801. Epub 2020 Sep 24. PMID: 32969115; PMCID: PMC7816806
Merlo M, Zaffalon D, Stolfo D, Altinier A, Barbati G, Zecchin M, Bardari S, Sinagra G (2019) ECG in dilated cardiomyopathy: specific findings and long-term prognostic significance. J Cardiovasc Med (Hagerstown) 20:450–458
Bejar D, Colombo PC, Latif F, Yuzefpolskaya M (2015) Infiltrative cardiomyopathies. Clin Med Insights Cardiol 9:29–38
CAS PubMed PubMed Central Google Scholar
Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, Ciliberti P, Pastorelli F, Biagini E, Coccolo F, Cooke RM, Bacchi-Reggiani L, Sangiorgi D, Ferlini A, Cavo M, Zamagni E, Fonte ML, Palladini G, Salinaro F, Musca F, Obici L, Branzi A, Perlini S (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120:1203–1212
Article CAS PubMed Google Scholar
Petri H, Vissing J, Witting N, Bundgaard H, Kober L (2012) Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol 160:82–88
Schoser BG, Ricker K, Schneider-Gold C, Hengstenberg C, Dürre J, Bültmann B, Kress W, Day JW, Ranum LP (2004) Sudden cardiac death in myotonic dystrophy type 2. Neurology 63:2402–2404
Article CAS PubMed Google Scholar
Emery AE (2000) Emery-Dreifuss muscular dystrophy - a 40 year retrospective. Neuromuscul Disord 10:228–232
Article CAS PubMed Google Scholar
Otomo J, Kure S, Shiba T, Karibe A, Shinozaki T, Yagi T, Naganuma H, Tezuka F, Miura M, Ito M, Watanabe J, Matsubara Y, Shirato K (2005) Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A/C gene. J Cardiovasc Electrophysiol 16:137–145
Peretto G, Sala S, Benedetti S, Di Resta C, Gigli L, Ferrari M, Della BP (2018) Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease. Nucleus (Austin, Tex) 9:380–391
Nery PB, Beanlands RS, Nair GM, Green M, Yang J, McArdle BA, Davis D, Ohira H, Gollob MH, Leung E, Healey JS, Birnie DH (2014) Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol 25:875–881
Gulati V, Harikrishnan P, Palaniswamy C, Aronow WS, Jain D, Frishman WH (2014) Cardiac involvement in hemochromatosis. Cardiol Rev 22:56–68
Sanna GD, Piga A, Parodi G, Sinagra G, Papadakis M, Pantazis A, Sharma S, Gati S, Finocchiaro G (2022) The electrocardiogram in the diagnosis and management of patients with left ventricular non-compaction. Curr Heart Fail Rep 19:476–490
Vitale G, Ditaranto R, Graziani F, Tanini I, Camporeale A, Lillo R, Rubino M, Panaioli E, Di Nicola F, Ferrara V, Zanoni R, Caponetti AG, Pasquale F, Graziosi M, Berardini A, Ziacchi M, Biffi M, Santostefano M, Liguori R, Taglieri N, Nardi E, Linhart A, Olivotto I, Rapezzi C, Biagini E (2022) Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy. Heart (British Cardiac Society) 108:54–60
Blum A, Podovitzky O, Sheiman J, Khasin M (2009) Reversal of first-degree atrioventricular block in Fabry disease. Arch Intern Med 169:1925–1926
Liu Y, Wang F, Chen X, Liang Y, Deng H, Liao H, Rao F, Wei W, Zhang Q, Zhang B, Zhan X, Fang X, Nair S, Shehata M, Wang X, Xue Y, Wu S (2018) Fasciculoventricular pathways responsible for ventricular preexcitation in patients with Danon disease. Circ Arrhythm Electrophysiol 11:e006704
Montañés ME, Granados MA, Valverde M, Palomino J, Fontenla A, Escribano L (2020) Wolff Parkinson white pattern in Danon disease: when preexcitation is not what it seems. J Electrocardiol 62:161–164
Forsha D, Li JS, Smith PB, van der Ploeg AT, Kishnani P, Pasquali SK (2011) Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy. Genet Med 13:625–631
Article CAS PubMed Google Scholar
Ansong AK, Li JS, Nozik-Grayck E, Ing R, Kravitz RM, Idriss SF, Kanter RJ, Rice H, Chen YT, Kishnani PS (2006) Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med 8:297–301
Article CAS PubMed Google Scholar
Porto AG, Brun F, Severini GM, Losurdo P, Fabris E, Taylor MRG, Mestroni L, Sinagra G (2016) Clinical spectrum of PRKAG2 syndrome. Circ Arrhythm Electrophysiol 9:e003121
Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM (2010) Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 12:114–121
Article CAS PubMed Google Scholar
Bates MG, Bourke JP, Giordano C, d’Amati G, Turnbull DM, Taylor RW (2012) Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J 33:3023–3033
Article CAS PubMed PubMed Central Google Scholar
Yeung C, Enriquez A, Suarez-Fuster L, Baranchuk A (2019) Atrial fibrillation in patients with inherited cardiomyopathies. Europace 21:22–32
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL and Group ESCSD (2020) ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021(42):373–498
Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524
Article CAS PubMed Google Scholar
Palyam V, Azam AT, Odeyinka O, Alhashimi R, Thoota S, Ashok T, Sange I (2022) Hypertrophic cardiomyopathy and atrial fibrillation: a review. Cureus 14:e21101
PubMed PubMed Central Google Scholar
Masri A, Kanj M, Thamilarasan M, Wazni O, Smedira NG, Lever HM, Desai MY (2017) Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis. Cardiovasc Diagn Ther 7:36–44
Article PubMed PubMed Central Google Scholar
Finocchiaro G, Merlo M, Sheikh N, De Angelis G, Papadakis M, Olivotto I, Rapezzi C, Carr-White G, Sharma S, Mestroni L, Sinagra G (2020) The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. Eur J Heart Fail 22:1097–1107
Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, Mannarino S, Gambarin F, Favalli V, Grasso M, Agozzino M, Campana C, Gavazzi A, Febo O, Marini M, Landolina M, Mortara A, Piccolo G, Vigano M, Tavazzi L, Arbustini E (2008) Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 52:1250–1260
Hasselberg NE, Haland TF, Saberniak J, Brekke PH, Berge KE, Leren TP, Edvardsen T, Haugaa KH (2018) Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J 39:853–860
Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31:186–194
Article CAS PubMed Google Scholar
Tayal U, Buchan Rachel J, Whiffin N, Newsome S, Mazzarotto F, Walsh R, Ware James S, Cook S, Prasad S (2016) 143 clinical and genetic characteristics of familial dilated cardiomyopathy in a large UK prospective cohort. Heart 102:A103–A104
Camm CF, James CA, Tichnell C, Murray B, Bhonsale A, te Riele AS, Judge DP, Tandri H, Calkins H (2013) Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm 10:1661–1668
Holmqvist F, Daubert JP (2013) Arrhythmogenic right ventricular cardiomyopathy: arrhythmias upstream and downstream. Heart Rhythm 10:1669–1670
Platonov PG, Christensen AH, Holmqvist F, Carlson J, Haunso S, Svendsen JH (2011) Abnormal atrial activation is common in patients with arrhythmogenic right ventricular cardiomyopathy. J Electrocardiol 44:237–241
Mazzanti A, Ng K, Faragli A, Maragna R, Chiodaroli E, Orphanou N, Monteforte N, Memmi M, Gambelli P, Novelli V, Bloise R, Catalano O, Moro G, Tibollo V, Morini M, Bellazzi R, Napolitano C, Bagnardi V, Priori SG (2016) Arrhythmogenic right ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk. J Am Coll Cardiol 68:2540–2550
Brescia ST, Rossano JW, Pignatelli R, Jefferies JL, Price JF, Decker JA, Denfield SW, Dreyer WJ, Smith O, Towbin JA, Kim JJ (2013) Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation 127:2202–2208
Murphy RT, Thaman R, Blanes JG, Ward D, Sevdalis E, Papra E, Kiotsekoglou A, Tome MT, Pellerin D, McKenna WJ, Elliott PM (2005) Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J 26:187–192
留言 (0)